Industries > Pharma > The Global Respiratory Inhalers Market 2020-2030

Back to Pharma Reports

The Global Respiratory Inhalers Market 2020-2030

Dry Powder Inhalers, Single-dose DPI, Multi-dose DPI, Metered Dose Inhalers, Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers, Asthma, COPD, Others

PUBLISHED: 28 January 2020

PAGES: 168

PRODUCT CODE: PHA0669

SUBMARKET: Medical Devices

SKU: PHA0669 Categories: Medical Devices, Pharma Tags: PHA0669, PHA0713, PHA0715, PHA0718

Visiongain estimates that the global respiratory inhalers market reached $xxbn in 2019 and will grow at a CAGR of xx% in the first half of the forecast period. In 2019, the Dry Powder Inhalers submarket held xx% of the global respiratory inhalers market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 168-page report you will receive 121 charts and 2 interviews– all unavailable elsewhere.

The 168-page report provides clear detailed insight into the respiratory inhalers market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

To access the data contained in this document please email contactus@visiongain.com

Report Scope

• Global Respiratory Inhalers Market from 2020-2030

• Forecast of the Global Respiratory Inhalers market by Type of Product:
• Metered Dose Inhalers (MDIs)
• Dry Powder Inhalers (DPIs): Single-dose DPIs, Multi-dose DPIs
• Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers

• Forecast of the Global Respiratory Inhalers market by Indication:
• Asthma
• COPD
• Other Respiratory Diseases

• This report provides individual revenue forecasts to 2030 for these national markets:
• The US
• Germany
• France
• UK
• Italy
• Spain
• Japan
• China
• India
• Russia
• Brazil
• Mexico
• Canada

• Our study discusses the selected leading companies that are the major players in the respiratory inhalers market:
• AstraZeneca
• Boehringer Ingelheim
• Chiesi Farmaceutici S.p.A.
• GlaxoSmithKline (GSK)
• Merck & Co.
• Novartis
• Teva

• This report discusses factors that drive and restrain this market. As well as opportunities and challenges faced by this market.

• This report discusses the Porter’s Five Forces Analysis of the respiratory inhalers market.

• Key questions answered by this report:
• How is the Respiratory Inhalers market evolving?
• What are the drivers and restraints for the growth of the Respiratory Inhalers market?
• What are the market shares of each segment of the overall Respiratory Inhalers market in 2020?
• How will each Respiratory Inhalers submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2030?
• How will the market shares for each Respiratory Inhalers submarket develop from 2020 to 2030?
• What will be the main driver for the overall market from 2020 to 2030?
• How will the market shares of the national markets change by 2030 and which geographical region will lead the market in 2030?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2020 and 2030?

Visiongain’s study is intended for anyone requiring commercial analyses for the respiratory inhalers market. You find data, trends and predictions.

Buy our report today The Global Respiratory Inhalers Market : Dry Powder Inhalers, Single-dose DPI, Multi-dose DPI, Metered Dose Inhalers, Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers, Asthma, COPD, Others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

1. Report Overview

1.1 Global Respiratory Inhalers Market Overview

1.2 Global Respiratory Inhalers Market Segmentation

1.3 Overview of Findings

1.4 Structure of the Report

1.5 Why You Should Read This Report

1.6 How This Report Delivers

1.7 Key Questions Answered by This Analytical Report

1.8 Who is This Report For?

1.9 Methodology

1.9.1 Primary Research

1.9.2 Secondary Research

1.9.3 Market Evaluation & Forecasting Methodology

1.10 Frequently Asked Questions (FAQ)

1.11 Associated Visiongain Reports

1.12 About Visiongain

2. Introduction to Respiratory Disorders and Therapies

2.1 An Introduction to Respiratory Disorders

2.1.1 Classification of Respiratory Disorders

2.1.2 Asthma

2.1.3 Chronic Obstructive Pulmonary Disease (COPD)

2.2 Major Drug Classes in the Treatment of Asthma and COPD

2.2.1 Bronchodilators

2.2.2 Phases of Clinical Trials

2.2.3 Regulation of Medical Devices

3. Respiratory Inhalers: Global Market Forecast 2020-2030

3.1 The Global Respiratory Inhalers Market in 2020

3.2 Leading Respiratory Inhaler Products

3.3 Leading Companies in the Respiratory Inhalers Market

3.4 Respiratory Inhalers: Trends and Developments

3.4.1 FDA Requires Replacement of CFC Inhalers with HFA Inhalers

3.4.2 The WISDOM Trial: Will Steroids Lose Their Role in COPD?

3.4.3 Telehealth: A Promising Market Trend

3.4.4 Lifecycle Management Strategies to Counter Patent Expiry

3.4.5 Advanced Inhaler Technologies to Counter Generic Erosion

4. Respiratory Inhalers Market by Product Type: Forecast 2020-2030

4.1 Metered Dose Inhalers: Market Forecast 2020-2030

4.2 Dry Powder Inhalers: Market Forecast 2020-2030

4.2.1 Single-Dose DPIs: Market Forecast 2020-2030

4.2.2 Multi-Dose DPIs: Market Forecast 2020-2030

4.3 Nebulizers: Market Forecast 2020-2030

4.3.1 Jet/Compressor Nebulizers: Market Forecast 2020-2030

4.3.2 Ultrasonic Nebulizers: Market Forecast 2020-2030

4.3.3 Vibrating-Mesh Nebulizers: Market Forecast 2020-2030

5. Respiratory Inhalers Market by Indication

5.1 Asthma: Market Forecast 2020-2030

5.2 COPD: Market Forecast 2020-2030

5.3 Other Respiratory Diseases: Market Forecast 2020-2030

6. Leading National Markets: Forecast 2020-2030

6.1 Regional Breakdown of the Global Respiratory Inhalers Market

6.2 World Respiratory Inhalers Market Forecast 2018-2030

6.2.1 How will Regional Market Shares Change to 2027?

6.3 The US Respiratory Inhalers Market 2020-2030

6.3.1 The US Respiratory Inhalers Market Forecast 2020-2030

6.3.2 US Respiratory Inhalers Market: Trends and Developments

6.4 EU5 Respiratory Inhalers Market 2020-2030

6.4.1 German Respiratory Inhalers Market Forecast 2020-2030

6.4.2 French Respiratory Inhalers Market Forecast 2020-2030

6.4.3 UK Respiratory Inhalers Market Forecast 2020-2030

6.4.4 Italian Respiratory Inhalers Market Forecast 2020-2030

6.4.5 Spanish Respiratory Inhalers Market Forecast 2020-2030

6.4.6 EU5 Respiratory Inhalers Market: Trends and Developments

6.5 Japanese Respiratory Inhalers Market 2018-2030

6.6 BRIC Respiratory Inhalers Market 2020-2030

6.6.1 Chinese Respiratory Inhalers Market Forecast 2020-2030

6.6.2 Indian Respiratory Inhalers Market Forecast 2020-2030

6.6.3 Brazilian Respiratory Inhalers Market Forecast 2020-2030

6.6.4 Russian Respiratory Inhalers Market Forecast 2020-2030

6.7 Mexican Respiratory Inhalers Market Forecast 2020-2030

6.8 Canadian Respiratory Inhalers Market Forecast 2020-2030

7. Leading Companies in the Respiratory Inhalers Market

7.1 GlaxoSmithKline (GSK)

7.1.1 GSK: Product Portfolio

7.1.2 GSK: Financial Overview

7.1.3 Recent Developments

7.2 AstraZeneca

7.2.1 AstraZeneca: Product Portfolio

7.2.2 AstraZeneca: Financial Overview

7.2.3 Recent Developments

7.2.4 AstraZeneca: Products in Development

7.3 Boehringer Ingelheim

7.3.1 Boehringer Ingelheim: Product Portfolio

7.3.2 Boehringer Ingelheim: Financial Overview

7.3.3 Recent Developments

7.3.4 Boehringer Ingelheim: Respiratory Product Pipeline

7.4 Merck & Co. (Merck)

7.4.1 Merck: Product Portfolio

7.4.2 Merck: Financial Overview

7.4.3 Recent Developments

7.4.4 Merck: Products in Development

7.5 Teva

7.5.1 Teva: Product Portfolio

7.5.2 Teva: Financial Overview

7.5.3 Teva: Recent Developments

7.5.4 Teva: Products in Development

7.6 Novartis International AG

7.6.1 Novartis: Product Portfolio

7.6.2 Novartis: Financial Overview

7.6.3 Novartis: Recent Developments

7.6.4 Novartis: Products Under Development

7.7 Chiesi Farmaceutici S.p.A.

7.7.1 Chiesi: Product Portfolio

7.7.2 Chiesi: Financial Overview

7.7.3 Chiesi: Recent Developments

8. Research Interviews

8.1 Professor Peter J Barnes, Professor of Medicine

8.1.1 Professor Peter J Barnes FRS, FMedSci, Margaret Turner-Warwick Professor of Medicine

8.1.2 Unmet needs of Asthma & COPD Patients

8.1.3 Personalization of Respiratory Disease Treatments

8.1.4 Changing Trends in Prevalence & Incidence

8.1.5 Changes in Class of Inhalers

8.2 David Van Sickle, CEO of Propeller Health

8.2.1 Propeller Health

8.2.2 Unmet needs of Asthma & COPD Patients

8.2.3 Proven Outcomes & Expansion of Propeller Health

8.2.4 Features of Propeller Health Sensors

8.2.5 Major Changes in This Decade

9. Qualitative Analysis of Respiratory Inhalers Market

9.1 Market Dynamics

9.1.1 Drivers and Opportunities

9.1.2 Restraints and Challenges

9.2 Porter’s Five Forces Analysis of the Respiratory Inhalers Market

9.2.1 Rivalry among Competitors [Medium]

9.2.2 Threat of New Entrants [Medium]

9.2.3 Power of Suppliers [Medium]

9.2.4 Power of Buyers [High]

9.2.5 Threat of Substitutes [Low]

10. Conclusions

10.1 Respiratory Inhalers: A Maturing Market

10.2 The Global Respiratory Inhalers Market, 2018 - 2030

10.3 Leading Respiratory Inhalers

10.4 Leading Respiratory Inhaler Companies

10.5 Leading Regional and National Markets

10.6 Global Respiratory Inhalers Market Forecast, 2020-2030

10.7 The Future of Respiratory Inhalers Market

Appendices

Glossary

Associated Visiongain Reports

Visiongain Report Sales Order Form

About Visiongain

Visiongain report evaluation form

List of Tables:

Table 2.1 Classification of Respiratory Diseases

Table 2.2 Clinical Trial Phases

Table 3.1 Top 5 Respiratory Inhalers: Revenue ($m) and Market Shares (%), 2018

Table 4.1 World Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Product Type, 2018-2030

Table 4.2 World Metered Dose Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 4.3 World Dry Powder Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), by Product Type, 2018-2030

Table 4.4 Types of Marketed Breezhaler Devices

Table 4.5 Single-dose DPI Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 4.6 Multi-dose DPI Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 4.7 World Nebulisers Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Type, 2018-2030

Table 4.8 World Jet Nebulisers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 4.9 World Ultrasonic Nebulisers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 4.10 World Vibrating-Mesh Nebulisers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 5.1 World Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Disease Indication, 2018-2030

Table 5.2 World Asthma Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 5.3 World COPD Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 5.4 World Respiratory Inhalers Market for Other Diseases, Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 6.1 World Respiratory Inhalers Market: Revenues ($m) and Market Shares (%) by Region, 2020

Table 6.2 World Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Region, 2018-2030

Table 6.3 Market Shares (%) of Leading Regional Respiratory Inhalers Markets, 2020, 2025 and 2030

Table 6.4 US Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 6.5 EU5 Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by National Market, 2018-2030

Table 6.6 German Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 6.7 French Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 6.8 UK Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 6.9 Italian Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 6.10 Spanish Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 6.11 Japanese Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 6.12 BRIC Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 6.13 Chinese Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 6.14 Indian Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 6.15 Brazilian Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 6.16 Russian Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 6.17 Mexican Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 6.18 Canadian Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Table 7.1 GSK: Overview

Table 7.2 GSK: Respiratory Inhaler Products

Table 7.3 GSK: Major Respiratory Inhalers Revenue ($m), AGR (%), CAGR (%) by Product Type, 2018-2030

Table 7.4 GSK: Respiratory Therapies Pipeline

Table 7.5 AstraZeneca: Overview

Table 7.6 AstraZeneca: Respiratory Inhaler Products

Table 7.7 AstraZeneca: Major Respiratory Inhalers Revenue ($m), AGR (%) and CAGR (%), by Product Type, 2018-2030

Table 7.8 AstraZeneca: Respiratory Therapies Pipeline

Table 7.9 Boehringer Ingelheim: Overview

Table 7.10 Boehringer Ingelheim: Respiratory Inhaler Products

Table 7.11 Boehringer Ingelheim: Major Respiratory Inhalers Revenue ($m), AGR (%) and CAGR (%) by Product Type, 2018-2030

Table 7.12 Merck: Overview

Table 7.13 Merck: Respiratory Inhaler Products

Table 7.14 Merck: Respiratory Inhalers Revenue ($m), AGR (%), CAGR (%) by Product Type, 2018-2030

Table 7.15 Teva: Overview

Table 7.16 Teva: Respiratory Inhaler Products

Table 7.17 Teva: Respiratory Inhalers Revenue ($m), AGR (%), CAGR (%) by Product Type, 2018-2030

Table 7.18 Teva: Respiratory Product Pipeline

Table 7.19 Novartis: Overview

Table 7.20 Novartis: Respiratory Inhaler Products

Table 7.21 Novartis: Respiratory Inhalers Revenue ($m), AGR (%), CAGR (%) by Product Type, 2018-2030

Table 7.22 Novartis: Respiratory Product Pipeline

Table 7.23 Chiesi: Overview

Table 7.24 Chiesi: Respiratory Inhaler Products

Table 7.25 Chiesi: Respiratory Inhalers Revenue ($m), AGR (%), CAGR (%) by Product Type, 2018-2030

Table 9.1 Top 5 Respiratory Inhalers: Revenue ($m) and Market Shares (%), 2018

List of Figures

Figure 1.1 Ageing Population Estimates 2010 - 2050

Figure 1.2 Global Respiratory Inhalers: Market Segmentation

Figure 2.1 Summary of GINA Guidance for Asthma Treatment, 2019

Figure 2.2 Summary of GOLD Guidance for COPD Treatment 2019

Figure 3.1 World Respiratory Inhalers Market: Market Shares (%) for Major National Markets 2020

Figure 3.2 Top 5 Respiratory Inhalers: Market Shares (%), 2018

Figure 4.1 Respiratory Inhalers Market Forecast: Revenues ($m) by Product Type, 2018-2030

Figure 4.2 Metered Dose Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 4.3 World Dry Powder Inhalers Market Forecast: Revenues ($m) by Product Type, 2018-2030

Figure 4.4 Single-dose DPI Market Forecast: Revenues ($m) and AGR (%), 2020-2030

Figure 4.5 Multi-dose DPI Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 4.6 World Jet Nebulisers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Figure 4.7 World Ultrasonic Nebulisers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Figure 4.8 World Vibrating-Mesh Nebulisers Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2018-2030

Figure 5.1 World Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Disease Indication, 2018-2030

Figure 5.2 World Asthma Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 5.3 World COPD Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 5.4 World Respiratory Inhalers Market for Other Diseases, Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 6.1 Respiratory Inhalers Market: Revenues ($m) by Region, 2020

Figure 6.2 World Respiratory Inhalers Market: Market Shares (%) by Region, 2020

Figure 6.3 World Respiratory Inhalers Market Forecast: Revenues ($m) by Region, 2018-2030

Figure 6.4 World Respiratory Inhalers Market: Market Shares (%) by Region, 2020

Figure 6.5 World Respiratory Inhalers Market: Market Shares (%) by Region, 2025

Figure 6.6 World Respiratory Inhalers Market: Market Shares (%) by Region, 2030

Figure 6.7 US Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 6.8 EU5 Respiratory Inhalers Market Forecast: Revenues ($m) by National Market, 2018-2030

Figure 6.9 German Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 6.10 French Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 6.11 UK Respiratory Inhalers Market Forecast: Revenues ($m), AGR (%), 2018-2030

Figure 6.12 Italian Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 6.13 Spanish Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 6.14 Japanese Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 6.15 BRIC Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 6.16 Chinese Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 6.17 Indian Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 6.18 Brazilian Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 6.19 Russian Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 6.20 Mexican Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 6.21 Canadian Respiratory Inhalers Market Forecast: Revenues ($m) and AGR (%), 2018-2030

Figure 7.1 GSK: Major Respiratory Inhalers Revenue ($m), 2018

Figure 7.2 GSK: Major Respiratory Inhalers Revenue Share (%) by Product, 2018

Figure 7.3 GSK: Major Respiratory Inhalers Revenue ($m) and AGR (%), 2018-2030

Figure 7.4 AstraZeneca: Major Respiratory Inhalers Revenue ($m), 2018

Figure 7.5 AstraZeneca: Major Respiratory Inhalers Revenue Share (%), by Product, 2018

Figure 7.6 AstraZeneca: Major Respiratory Inhalers Revenue ($m) and AGR (%), 2018-2030

Figure 7.7 Boehringer Ingelheim: Major Respiratory Inhalers Revenue ($m), 2018

Figure 7.8 Boehringer Ingelheim: Major Respiratory Inhalers Revenue Share (%), by Product, 2018

Figure 7.9 Boehringer Ingelheim: Major Respiratory Inhalers Revenue ($m) and AGR (%), 2018-2030

Figure 7.10 Merck: Major Respiratory Inhalers Revenue ($m), 2018

Figure 7.11 Merck: Major Respiratory Inhalers Revenue Share (%) by Product, 2018

Figure 7.12 Merck: Major Respiratory Inhalers Revenue ($m) and AGR (%), 2018-2030

Figure 7.13 Teva: Major Respiratory Inhalers Revenue ($m), 2018

Figure 7.14 Teva: Major Respiratory Inhalers Revenue Share (%) by Product, 2018

Figure 7.15 Teva: Major Respiratory Inhalers Revenue ($m) and AGR (%), 2018-2030

Figure 7.16 Novartis: Major Respiratory Inhalers Revenue ($m), 2017

Figure 7.17 Novartis: Major Respiratory Inhalers Revenue Share (%), by Product, 2018

Figure 7.18 Novartis: Major Respiratory Inhalers Revenue ($m) and AGR (%), 2018-2030

Figure 7.19 Chiesi: Foster Inhaler Revenue ($m) and AGR (%), 2018-2030

Figure 8.1 Porter’s Five Forces Analysis of the Respiratory Inhalers Market, 2018-2030

Figure 9.1 Respiratory Inhalers Market Forecast: Revenues ($m) by Product Type, 2018-2030

3M Drug Delivery Systems

Actavis

Adherium Limited

Aerogen

Agilent Technology

Airssential

Allied Healthcare

Almirall

Astrazeneca

Boehringer Ingelheim

Briggs Healthcare

CareFusion

Chiesi

Circassia Pharmaceuticals plc

Cipla

Clement Clarke International

Cohero Health

DeVilbiss Healthcare

Fexicare

Gecko Health Innovations

GF Health Products

GlaxoSmithKline

Heyer Medical

Hikma

IBM Watson Health

Innovate Biomed

Innoviva

Inspiro Medical

Mabis Healthcare

Medline Surgical

Merck

MRK Healthcare

Mylan

Nexus 6

Nouvag AG

Novartis

Omron Healthcare

Opko Health

Orion Pharma

PARI Medical

Pfizer

Philips Respironics

Propeller Health

Qualcomm Incorporated

Roche

Schering-Plough

Sunovion Pharma

Takeda Pharmaceutical Company Limited

Teva Pharmaceuticals

Theravance

Vectura

Viatris

List of Organizations Mentioned in the Report

Academia Europaea

American College of Chest Physicians

American Thoracic Society

British Lung Foundation

Catholic University of Leuven

Centers for Disease Control and Prevention

Centre for Devices and Radiological Health

European Databank on Medical Devices

European Medicines Agency

European Respiratory Society

Food and Drug Administration

German Ministry of Health

Global Initiative for Asthma

Global Initiative for Chronic Obstructive Lung Disease

IBM Watson Health

Imperial College, London

Journal of COPD Foundation

Kaohsiung Medical University

Margaret Turner Warwick Education Centre

Ministry of Health, Labour and Welfare

Mount Sinai Hospital

MRC Technology

National Heart and Lung Institute

National Institute for Health Research

Royal College of Physicians

Royal Society

ServicioSanitarioNazionale

Tampere University

UK NHS

the Universities of Athens

University of Cambridge

University of Ferrara

University of Oxford

Up-to-Date Pulmonary Diseases

US National Heart, Lung, and Blood Institute

US National Institutes of Health

Weill Cornell Medicine

World Health Organization (WHO)

Download sample pages

Complete the form below to download your free sample pages for The Global Respiratory Inhalers Market 2020-2030

Download sample pages

Complete the form below to download your free sample pages for The Global Respiratory Inhalers Market 2020-2030

Case studies

Need customized work?

Report overview

Methodology

Client testimonials

Pharmaceutical industry associations

American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Connect with us

Visiongain Pharma

Latest Pharma news

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033

The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.

25 September 2023

READ

Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.

21 September 2023

READ

Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033

The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.

14 September 2023

READ

Visiongain Publishes Stem Cell Therapy Contract Manufacturing Market Report 2023-2033

The global Stem Cell Therapy Contract Manufacturing market was valued at US$2,495.1 million in 2022 and is projected to grow at a CAGR of 12.4% during the forecast period 2023-2033.

13 September 2023

READ

Industries > Pharma > The Global Respiratory Inhalers Market 2020-2030

Back to Pharma Reports

The Global Respiratory Inhalers Market 2020-2030

Dry Powder Inhalers, Single-dose DPI, Multi-dose DPI, Metered Dose Inhalers, Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers, Asthma, COPD, Others

Download sample pages

Related reports

Cell Therapy Technologies Market Forecast 2020-2030

Global Neurostimulation Devices Market 2019-2029

Global Precision Medicine Market Forecast 2019-2029

Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market Forecast to 2029

Global Asthma & COPD Therapies Market 2019-2029

Global Medical Device Contract Manufacturing Market Forecast 2019-2029

Top 20 Global Respiratory Inhalers Manufacturers 2019

Global Pharma Contract Sales Market Forecast 2020-2030

Pharma Leader Series: Top 20 Asthma & COPD Companies 2019-2029

Pharma Leader Series: Top 55 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2020

Download sample pages

Share

Connect with us

Latest Pharma news

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033

Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033

Visiongain Publishes Stem Cell Therapy Contract Manufacturing Market Report 2023-2033

Our Clients